BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9657474)

  • 1. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.
    Jung WI; Sieverding L; Breuer J; Hoess T; Widmaier S; Schmidt O; Bunse M; van Erckelens F; Apitz J; Lutz O; Dietze GJ
    Circulation; 1998 Jun; 97(25):2536-42. PubMed ID: 9657474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
    Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
    J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
    Sieverding L; Jung WI; Breuer J; Widmaier S; Staubert A; van Erckelens F; Schmidt O; Bunse M; Hoess T; Lutz O; Dietze GJ; Apitz J
    Am J Cardiol; 1997 Aug; 80(3A):34A-40A. PubMed ID: 9293954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
    Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.
    Sakuma H; Takeda K; Tagami T; Nakagawa T; Okamoto S; Konishi T; Nakano T
    Am Heart J; 1993 May; 125(5 Pt 1):1323-8. PubMed ID: 8480584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of myocardial energy metabolism by 31 P-magnetic resonance spectroscopy in patients with hypertrophic cardiomyopathy versus healthy individuals].
    Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE
    Vestn Rentgenol Radiol; 2012; (6):8-12. PubMed ID: 23520935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy.
    de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA
    J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human.
    Jung WI; Dietze GJ
    Am J Cardiol; 1999 Jun; 83(12A):19H-24H. PubMed ID: 10750582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
    Okada M; Mitsunami K; Inubushi T; Kinoshita M
    Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
    Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
    Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Yabe T; Inubushi T; Morikawa S; Matsuo S; Koh T; Horie M
    J Cardiovasc Magn Reson; 2004; 6(3):685-96. PubMed ID: 15347133
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Secchi F; Di Leo G; Petrini M; Spairani R; Alì M; Guazzi M; Sardanelli F
    Radiol Med; 2017 Apr; 122(4):265-272. PubMed ID: 28070839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.
    Masuda Y; Tateno Y; Ikehira H; Hashimoto T; Shishido F; Sekiya M; Imazeki Y; Imai H; Watanabe S; Inagaki Y
    Jpn Circ J; 1992 Jun; 56(6):620-6. PubMed ID: 1625368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy.
    Massie BM; Schaefer S; Garcia J; McKirnan MD; Schwartz GG; Wisneski JA; Weiner MW; White FC
    Circulation; 1995 Mar; 91(6):1814-23. PubMed ID: 7882492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.
    Yabe T; Mitsunami K; Okada M; Morikawa S; Inubushi T; Kinoshita M
    Circulation; 1994 Apr; 89(4):1709-16. PubMed ID: 8149536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.